Skip Navigation
Skip to contents

JPMPH : Journal of Preventive Medicine and Public Health

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
13 "Cost of illness"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Special Article
Measuring Trends in the Socioeconomic Burden of Disease in Korea, 2007-2015
Tae Eung Kim, Ru-Gyeom Lee, So-Youn Park, In-Hwan Oh
J Prev Med Public Health. 2022;55(1):19-27.   Published online January 31, 2022
DOI: https://doi.org/10.3961/jpmph.21.594
  • 4,838 View
  • 157 Download
  • 6 Web of Science
  • 6 Crossref
AbstractAbstract AbstractSummary PDFSupplementary Material
This study estimated the direct and indirect socioeconomic costs of 238 diseases and 22 injuries from a social perspective in Korea from 2007 to 2015. The socioeconomic cost of each disease group was calculated based on the Korean Standard Disease Classification System. Direct costs were estimated using health insurance claims data provided by the National Health Insurance Service. The numbers of outpatients and inpatients with the main diagnostic codes for each disease were selected as a proxy indicator for estimating patients’ medical use behavior by disease. The economic burden of disease from 2007 to 2015 showed an approximately 20% increase in total costs. From 2007 to 2015, communicable diseases (including infectious, maternal, pediatric, and nutritional diseases) accounted for 8.9-12.2% of the socioeconomic burden, while non-infectious diseases accounted for 65.7-70.7% and injuries accounted for 19.1-22.8%. The top 5 diseases in terms of the socioeconomic burden were self-harm (which took the top spot for 8 years), followed by cirrhosis of the liver, liver cancer, ischemic heart disease, and upper respiratory infections in 2007. Since 2010, the economic burden of conditions such as low back pain, falls, and acute bronchitis has been included in this ranking. This study expanded the scope of calculating the burden of disease at the national level by calculating the burden of disease in Koreans by gender and disease. These findings can be used as indicators of health equality and as useful data for establishing community-centered (or customized) health promotion policies, projects, and national health policy goals.
Summary
Korean summary
2007년에서 2015년 기간의 건강보험 자료 등을 이용하여, 해당기간의 경제적 질병부담을 측정하였으며, 해당 기간동안 경제적 질병부담은 20%의 증가를 나타내었다. 동 기간동안 비감염성 질환의 경제적 질병부담의 비율은 약 70%로 나타났으며, 감염성 질환은 약 10%, 손상은 20%로 나타났다. 한편 개별 질병군 기준으로는 자살을 포함한 자해가 1위를 차지한 해가 가장 많았다.

Citations

Citations to this article as recorded by  
  • Time Trend Analysis of Comorbidities in Ankylosing Spondylitis: A Population-Based Study from 53,142 Hospitalizations in Poland
    Katarzyna Helon, Małgorzata Wisłowska, Krzysztof Kanecki, Paweł Goryński, Aneta Nitsch-Osuch, Krzysztof Bonek
    Journal of Clinical Medicine.2024; 13(2): 602.     CrossRef
  • Association between accelerometer-derived physical activity and depression: a cross-sectional study using isotemporal substitution analysis
    Jungmi Park, Hee-Kyoung Nam, Sung-Il Cho
    BMJ Open.2024; 14(4): e078199.     CrossRef
  • Assessment and nonsurgical management of low back pain: a narrative review
    Sung Cheol Park, Min-Seok Kang, Jae Hyuk Yang, Tae-Hoon Kim
    The Korean Journal of Internal Medicine.2023; 38(1): 16.     CrossRef
  • Therapeutic Duplication as a Medication Error Risk in Fixed-Dose Combination Drugs for Dyslipidemia: A Nationwide Study
    Wonbin Choi, Hyunji Koo, Kyeong Hye Jeong, Eunyoung Kim, Seung-Hun You, Min-Taek Lee, Sun-Young Jung
    Korean Journal of Clinical Pharmacy.2023; 33(3): 168.     CrossRef
  • Effects of a Senior Musical Program on the Physical Function and Cognitive Abilities of Older Women in the Community
    Byeong-Soo Kim, Ji-Youn Kim, Sam-Ho Park, Myung-Mo Lee
    Healthcare.2023; 11(8): 1174.     CrossRef
  • Estimated trends in hospitalizations due to occupational injuries in Korea based on the Korean National Hospital Discharge In-depth Injury Survey (2006-2019)
    Seong-Uk Baek, Won-Tae Lee, Min-Seok Kim, Myeong-Hun Lim, Jin-Ha Yoon
    Epidemiology and Health.2023; 45: e2023042.     CrossRef
Original Article
Estimating Influenza-associated Mortality in Korea: The 2009-2016 Seasons
Kwan Hong, Sangho Sohn, Byung Chul Chun
J Prev Med Public Health. 2019;52(5):308-315.   Published online August 23, 2019
DOI: https://doi.org/10.3961/jpmph.19.156
  • 21,730 View
  • 329 Download
  • 15 Crossref
AbstractAbstract AbstractSummary PDF
Objectives
Estimating influenza-associated mortality is important since seasonal influenza affects persons of all ages, causing severe illness or death. This study aimed to estimate influenza-associated mortality, considering both periodic changes and age-specific mortality by influenza subtypes.
Methods
Using the Microdata Integrated Service from Statistics Korea, we collected weekly mortality data including cause of death. Laboratory surveillance data of respiratory viruses from 2009 to 2016 were obtained from the Korea Centers for Disease Control and Prevention. After adjusting for the annual age-specific population size, we used a negative binomial regression model by age group and influenza subtype.
Results
Overall, 1 859 890 deaths were observed and the average rate of influenza virus positivity was 14.7% (standard deviation [SD], 5.8), with the following subtype distribution: A(H1N1), 5.0% (SD, 5.8); A(H3N2), 4.4% (SD, 3.4); and B, 5.3% (SD, 3.7). As a result, among individuals under 65 years old, 6774 (0.51%) all-cause deaths, 2521 (3.05%) respiratory or circulatory deaths, and 1048 (18.23%) influenza or pneumonia deaths were estimated. Among those 65 years of age or older, 30 414 (2.27%) all-cause deaths, 16 411 (3.42%) respiratory or circulatory deaths, and 4906 (6.87%) influenza or pneumonia deaths were estimated. Influenza A(H3N2) virus was the major contributor to influenza-associated all-cause and respiratory or circulatory deaths in both age groups. However, influenza A(H1N1) virus–associated influenza or pneumonia deaths were more common in those under 65 years old.
Conclusions
Influenza-associated mortality was substantial during this period, especially in the elderly. By subtype, influenza A(H3N2) virus made the largest contribution to influenza-associated mortality.
Summary
Korean summary
계절 인플루엔자는 심각한 호흡기 합병증으로 진행할 수 있어 질병 부담의 추산이 중요한 질병이다. 현재까지는 연령별, 인플루엔자 연관 사망을 정확하게 추산하기 어려웠으나, 본 연구에서는 이를 추산하기 위해 고안된 다양한 방법 중 음이항 회귀 분석을 이용하여 2009년부터 2016년간 인플루엔자 아형별 연관 사망을 추산하였다. 그 결과, 전체 사망자 중 65세 미만에서 약 6,774명, 65세 이상에서 약 30,414명의 연간 인플루엔자 사망이 추산되었고, 이는 특히 인플루엔자 아형 중 전체 연령에서 A(H3N2) 연관 사망이 가장 많은 비율을 차지했다.

Citations

Citations to this article as recorded by  
  • Influenza vaccination before and during the COVID-19 pandemic in the elderly in South Korea
    Dong Jun Kim, Kyoung Hee Cho, Seongju Kim, Hooyeon Lee
    Journal of Infection and Public Health.2024; 17(3): 503.     CrossRef
  • An 8-Year Prospective, Observational, Multi-centre Post-Marketing Safety Surveillance Study Conducted in South Korea (2014–2022) Following the Introduction of GSK’s Inactivated Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) for Subjects Aged 6 Mo
    Gaël Dos Santos, Raghavendra Devadiga, Chun Soo Kim, Joon Bang
    Drug Safety.2024; 47(4): 365.     CrossRef
  • Influenza disease burden and the need for highly immunogenic vaccines in older adults: a narrative review
    Joon Young Song
    The Ewha Medical Journal.2024;[Epub]     CrossRef
  • Incidence, Severity, and Mortality of Influenza During 2010–2020 in Korea: A Nationwide Study Based on the Population-Based National Health Insurance Service Database
    Soo-Hee Hwang, Hyejin Lee, Myunghoo Jung, Sang-Hyun Kim, Ho Kyung Sung, Myoung-don Oh, Jin Yong Lee
    Journal of Korean Medical Science.2023;[Epub]     CrossRef
  • Impact of the COVID-19 Pandemic on Influenza Vaccination and Associated Factors among Pregnant Women: A Cross-Sectional Study in Korea
    Boyeon Kim, Eunyoung Kim
    Vaccines.2023; 11(3): 512.     CrossRef
  • Influenza Vaccination Rate and Related Factors in Korean Adults During the Coronavirus Disease 2019 Epidemic
    Kyung Wan Kwon, Ka Hyeon Bae, Jeong Hwan Park, Tae Oh Kim, Jin Young Kim, Seung Min Baek, Sang Hyun Park, Ju Young Lee, Bo Hyun Park, Mi Ah Han
    Asia Pacific Journal of Public Health.2023; 35(2-3): 217.     CrossRef
  • Post-Marketing Safety Surveillance of Quadrivalent Influenza Vaccine (VaxigripTetra) in Children Aged 6 to 35 Months in South Korea
    Sunho Choe, Oxana Talanova, Sooyoun Shin, Olga Syrkina, Marion Fournier
    Infectious Diseases and Therapy.2023; 12(6): 1715.     CrossRef
  • All-Cause and Cause-Specific Mortality Attributable to Seasonal Influenza: A Nationwide Matched Cohort Study
    Heeseon Jang, Jaelim Cho, Seong-Kyung Cho, Donghan Lee, Sung-il Cho, Sang-Baek Koh, Dong-Chun Shin, Changsoo Kim
    Journal of Korean Medical Science.2023;[Epub]     CrossRef
  • Global trends of seasonal influenza-associated mortality in 2001–2018: A longitudinal epidemiological study
    Hideharu Hagiya, Yuka Osaki, Michio Yamamoto, Takahiro Niimura, Ko Harada, Tsukasa Higashionna, Hirofumi Hamano, Yoshito Zamami, Shiro Hinotsu, Toshihiro Koyama
    Journal of Infection.2023; 87(3): e54.     CrossRef
  • Analysis of the effectiveness of non-pharmaceutical interventions on influenza during the Coronavirus disease 2019 pandemic by time-series forecasting
    Hyun Kyung Kim, Kyung-Duk Min, Sung-il Cho
    BMC Infectious Diseases.2023;[Epub]     CrossRef
  • Systematic review of influenza vaccine effectiveness against laboratory-confirmed influenza among older adults living in aged care facilities
    Aye Moa, Mohana Kunasekaran, Zubair Akhtar, Valentina Costantino, C. Raina MacIntyre
    Human Vaccines & Immunotherapeutics.2023;[Epub]     CrossRef
  • The Influence of Gaseous Pollutants Concentration on Influenza Outbreak Risk
    晓璐 马
    Open Journal of Natural Science.2023; 11(06): 1003.     CrossRef
  • The impact of free vaccination policies under the Korean Influenza National Immunization Program: Trends in influenza vaccination rates in South Korea from 2010 to 2019
    Jeongmin Seo, Juwon Lim, Dong Keon Yon
    PLOS ONE.2022; 17(1): e0262594.     CrossRef
  • Post-marketing Surveillance of a Quadrivalent Influenza Vaccine (Vaxigrip Tetra) in South Korea
    Sookyung Lim, Xiaoling Li, Olga Syrkina, Marion Fournier
    Infectious Diseases and Therapy.2022; 11(5): 2035.     CrossRef
  • Novel respiratory infectious diseases in Korea
    Hyun Jung Kim
    Yeungnam University Journal of Medicine.2020; 37(4): 286.     CrossRef
Special Article
Strategies for Appropriate Patient-centered Care to Decrease the Nationwide Cost of Cancers in Korea
Jong-Myon Bae
J Prev Med Public Health. 2017;50(4):217-227.   Published online June 16, 2017
DOI: https://doi.org/10.3961/jpmph.17.069
  • 7,067 View
  • 158 Download
  • 2 Crossref
AbstractAbstract PDFSupplementary Material
In terms of years of life lost to premature mortality, cancer imposes the highest burden in Korea. In order to reduce the burden of cancer, the Korean government has implemented cancer control programs aiming to reduce cancer incidence, to increase survival rates, and to decrease cancer mortality. However, these programs may paradoxically increase the cost burden. For examples, a cancer screening program for early detection could bring about over-diagnosis and over-treatment, and supplying medical services in a paternalistic manner could lead to defensive medicine or futile care. As a practical measure to reduce the cost burden of cancer, appropriate cancer care should be established. Ensuring appropriateness requires patient-doctor communication to ensure that utility values are shared and that autonomous decisions are made regarding medical services. Thus, strategies for reducing the cost burden of cancer through ensuring appropriate patient-centered care include introducing value-based medicine, conducting cost-utility studies, and developing patient decision aids.
Summary

Citations

Citations to this article as recorded by  
  • A Systematic Review of Economic Evaluation of Thyroid Cancer
    Mijin Kim, Woojin Lim, Kyungsik Kim, Ja Seong Bae, Byung Joo Lee, Bon Seok Koo, Eun Kyung Lee, Eu Jeong Ku, June Young Choi, Bo Hyun Kim, Sue K. Park
    International Journal of Thyroidology.2022; 15(2): 74.     CrossRef
  • Ethical, pedagogical, socio-political and anthropological implications of quaternary prevention
    Marc Jamoulle, Michel Roland, Jong-Myon Bae, Bruno Heleno, Giorgio Visentin, Gustavo Diniz Ferreira Gusso, Maciek Godycki-Ćwirko, Miguel Pizzanell, Patrick Ouvrard, Ricardo La Valle, Luis Filipe Gomes, Daniel Widmer, Jorge Bernstein, Mariana Mariño, Hamil
    Revista Brasileira de Medicina de Família e Comunidade.2018; 13(40): 1.     CrossRef
Original Articles
Economic Burden of Colorectal Cancer in Korea
Ju-Young Byun, Seok-Jun Yoon, In-Hwan Oh, Young Ae Kim, Hye-Young Seo, Yo-Han Lee
J Prev Med Public Health. 2014;47(2):84-93.   Published online March 31, 2014
DOI: https://doi.org/10.3961/jpmph.2014.47.2.84
  • 14,959 View
  • 148 Download
  • 18 Crossref
AbstractAbstract PDF
Objectives

The incidence and survival rate of colorectal cancer in Korea are increasing because of improved screening, treatment technologies, and lifestyle changes. In this aging population, increases in economic cost result. This study was conducted to estimate the economic burden of colorectal cancer utilizing claims data from the Health Insurance Review and Assessment Service.

Methods

Economic burdens of colorectal cancer were estimated using prevalence data and patients were defined as those who received ambulatory treatment from medical institutions or who had been hospitalized due to colorectal cancer under the International Classification of Disease 10th revision codes from C18-C21. The economic burdens of colorectal cancer were calculated as direct costs and indirect costs.

Results

The prevalence rate (per 100 000 people) of those who were treated for colorectal cancer during 2010 was 165.48. The economic burdens of colorectal cancer in 2010 were 3 trillion and 100 billion Korean won (KRW), respectively. Direct costs included 1 trillion and 960 billion KRW (62.85%), respectively and indirect costs were 1 trillion and 160 billion (37.15%), respectively.

Conclusions

Colorectal cancer has a large economic burden. Efforts should be made to reduce the economic burden of the disease through primary and secondary prevention.

Summary

Citations

Citations to this article as recorded by  
  • Estimating the economic burden of colorectal cancer in China, 2019–2030: A population‐level prevalence‐based analysis
    Hong Wang, Yan‐Jie Li, Lin Lei, Cheng‐Cheng Liu, Wan‐Qing Chen, Min Dai, Xin Wang, Jie‐Bin Lew, Ju‐Fang Shi, Ni Li, Jie He
    Cancer Medicine.2024;[Epub]     CrossRef
  • Relationship Between Aspirin Use and Site-Specific Colorectal Cancer Risk Among Individuals With Metabolic Comorbidity
    Seokyung An, Madhawa Gunathilake, Jeonghee Lee, Minji Kim, Jae Hwan Oh, Hee Jin Chang, Dae Kyung Sohn, Aesun Shin, Jeongseon Kim
    Journal of Korean Medical Science.2024;[Epub]     CrossRef
  • Cost of illness for colorectal cancer in Japan - a time trend and future projections (1996–2035) based on governmental statistics
    Kunichika Matsumoto, Yosuke Hatakeyama, Kanako Seto, Ryo Onishi, Koki Hirata, Yinghui Wu, Tomonori Hasegawa
    BMC Health Services Research.2023;[Epub]     CrossRef
  • Colorectal cancer-related resource utilization and healthcare costs in Saudi Arabia
    Bander Balkhi, Ahmed Alghamdi, Saeed Alqahtani, Marwan Al Najjar, Abdullah Al Harbi, Thamer Bin Traiki
    Saudi Pharmaceutical Journal.2023; 31(11): 101822.     CrossRef
  • A performance measurement framework for socially sustainable and resilient supply chains using environmental goods valuation methods
    Aref A. Hervani, Santosh Nandi, Marilyn M. Helms, Joseph Sarkis
    Sustainable Production and Consumption.2022; 30: 31.     CrossRef
  • Direct medical costs of young-onset colorectal cancer: a worldwide systematic review
    Ria Garg, Vicki Cheng, Ursula Ellis, Vanay Verma, Helen McTaggart-Cowan, Stuart Peacock, Jonathan M. Loree, Mohsen Sadatsafavi, Mary A. De Vera
    BMC Health Services Research.2022;[Epub]     CrossRef
  • Economic Burden of Colorectal Cancer: A Case of Fars, Iran
    Abdosaleh Jafari, Peyman Mehdi Alamdarloo, Mehdi Dehghani, Peivand Bastani, Ramin Ravangard
    Cancer Control.2021;[Epub]     CrossRef
  • Quality of life and costs of patients prior to colorectal surgery
    M. Pattamatta, B. J. J. Smeets, S. M. A. A. Evers, E. G. Peters, M. D. P. Luyer, M. Hiligsmann
    Expert Review of Pharmacoeconomics & Outcomes Research.2020; 20(2): 193.     CrossRef
  • Socioeconomic Burden of Cancer in Korea from 2011 to 2015
    Young Ae Kim, Ye-Rin Lee, Jeongjoo Park, In-Hwan Oh, Hoseob Kim, Seok-Jun Yoon, Keeho Park
    Cancer Research and Treatment.2020; 52(3): 896.     CrossRef
  • The Direct and Indirect Costs of Colorectal Cancer in Vietnam: An Economic Analysis from a Social Perspective
    Binh Thang Tran, Kui Son Choi, Thanh Xuan Nguyen, Dae Kyung Sohn, Sun-Young Kim, Jae Kyung Suh, Van Sang Phan, Huu Tri Pham, Minh Hanh Nguyen, Thanh Binh Nguyen, Huu Khoi Hoang, Thi Thanh Binh Nguyen, Minh Tu Nguyen, Jin-Kyoung Oh
    International Journal of Environmental Research and Public Health.2020; 18(1): 12.     CrossRef
  • Emerging hazard effects of proton pump inhibitor on the risk of colorectal cancer in low-risk populations: A Korean nationwide prospective cohort study
    In Cheol Hwang, Jooyoung Chang, Sang Min Park, Suminori Akiba
    PLOS ONE.2017; 12(12): e0189114.     CrossRef
  • Analysis of Productivity Costs in Cancer: A Systematic Review
    Jordi Gol-Montserrat, María Luisa M. del Burgo, Luis Quecedo, Juan E. del Llano
    Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish.2017; 4(1): grhta.5000262.     CrossRef
  • The Economic Burden of Hepatitis A, B, and C in South Korea
    Changwoo Shon, Hyung-Yun Choi, Jae-Jun Shim, So-Youn Park, Kyung Suk Lee, Seok-Jun Yoon, In-Hwan Oh
    Japanese Journal of Infectious Diseases.2016; 69(1): 18.     CrossRef
  • Dehydroglyasperin D Inhibits the Proliferation of HT-29 Human Colorectal Cancer Cells Through Direct Interaction With Phosphatidylinositol 3-kinase
    Sung Keun Jung, Chul-Ho Jeong
    Journal of Cancer Prevention.2016; 21(1): 26.     CrossRef
  • The Economic Burden of Cancer in Korea in 2009
    So Young Kim, Jong-Hyock Park, Kyoung Hee Kang, Inuk Hwang, Hyung Kook Yang, Young-Joo Won, Hong-Gwan Seo, Dukhyoung Lee, Seok-Jun Yoon
    Asian Pacific Journal of Cancer Prevention.2015; 16(3): 1295.     CrossRef
  • The Economic Burden of Cancers Attributable to Metabolic Syndrome in Korea
    Dongwoo Kim, Seok-Jun Yoon, Young-Hoon Gong, Young Ae Kim, Hye-Young Seo, Jihyun Yoon, A-Rim Kim
    Journal of Preventive Medicine and Public Health.2015; 48(4): 180.     CrossRef
  • Trends in Colorectal Cancer Incidence in Daejeon and Chungcheongnam-do, South Korea (2000-2012)
    Soon-Young Kim, In-Sun Kweon, Jung-A Kim, Tae-Yong Lee, Hae-Sung Nam
    Journal of agricultural medicine and community health.2015; 40(3): 115.     CrossRef
  • FOXM1-mediated downregulation of uPA and MMP9 by 3,3′-diindolylmethane inhibits migration and invasion of human colorectal cancer cells
    HUA JIN, XIU JUAN LI, MAN HEE PARK, SOO MI KIM
    Oncology Reports.2015; 33(6): 3171.     CrossRef
The Economic Burden of Epilepsy in Korea, 2010
Jaehun Jung, Hye-Young Seo, Young Ae Kim, In-Hwan Oh, Yo Han Lee, Seok-Jun Yoon
J Prev Med Public Health. 2013;46(6):293-299.   Published online November 28, 2013
DOI: https://doi.org/10.3961/jpmph.2013.46.6.293
  • 10,216 View
  • 127 Download
  • 11 Crossref
AbstractAbstract PDF
Objectives

The purposes of this study were to evaluate the prevalence of epilepsy and to estimate the cost of epilepsy in Korea, 2010.

Methods

This study used a prevalence based approach to calculate the cost of epilepsy. Claims data from the Korean national health insurance and data from the Korea health panel, the Korea National Statistical Office's records of causes of death, and labor statistics were used to estimate the cost of epilepsy. Patients were defined as those who were hospitalized or visited an outpatient clinic during 2010 with a diagnosis of epilepsy (International Classification of Diseases 10th revision codes G40-G41). Total costs of epilepsy included direct medical costs, direct non-medical cost and indirect costs.

Results

The annual prevalence of treated epilepsy was 228 per 100 000 population, and higher in men. The age-specific prevalence was highest for teenagers. The total economic burden of epilepsy was 536 billion Korean won (KW). Indirect cost (304 billion KW) was 1.3 times greater than direct cost (232 billion KW). By gender, the male (347 billion KW) were more burdened than the female (189 billion KW). The estimated cost in young age younger than 20 years old was 24.5% of the total burden of epilepsy.

Conclusions

A significant portion of the economic burden of epilepsy is borne by people in young age. To reduce the economic burden of epilepsy, effective prevention and treatment strategies are needed.

Summary

Citations

Citations to this article as recorded by  
  • Economic assessment of convulsive status epilepticus: Investigating socioeconomic correlations in hospitalization costs and outcomes in Northern India
    Ahmad Ghayas Ansari, Ariba Nasar, Hiba Nasar
    IP Indian Journal of Neurosciences.2024; 10(2): 78.     CrossRef
  • Evaluation of persistence and healthcare utilization in patients treated with anti-seizure medications as add-on therapy: A nationwide cohort study in South Korea
    Ji Woong Lee, Jung-Ae Kim, Min Young Kim, Sang Kun Lee
    Epilepsy & Behavior.2022; 126: 108459.     CrossRef
  • Cost of Illness of Epilepsy and Associated Factors in Patients Attending Adult Outpatient Department of University of Gondar Referral Hospital, Northwest Ethiopia
    Piniel Melkamu, Yaregal Animut, Amare Minyihun, Asmamaw Atnafu, Mezgebu Yitayal
    Risk Management and Healthcare Policy.2021; Volume 14: 2385.     CrossRef
  • Cost–benefit analysis, cost-effectiveness analysis, and impact of antiepileptic drugs on the risk of fracture in patients with epilepsy: A nationwide cohort study
    Hsin-Hsuan Cheng, Pei-Tseng Kung, Bo-Ren Wang, Li-Ting Chiu, Wen-Chen Tsai
    Epilepsy & Behavior.2020; 103: 106851.     CrossRef
  • Introducing big data analysis using data from National Health Insurance Service
    EunJin Ahn
    Korean Journal of Anesthesiology.2020; 73(3): 205.     CrossRef
  • Epilepsy in Asia: Disease burden, management barriers, and challenges
    Eugen Trinka, Patrick Kwan, ByungIn Lee, Amitabh Dash
    Epilepsia.2019; 60(S1): 7.     CrossRef
  • The Present and Future of Vagus Nerve Stimulation
    Jeyul Yang, Ji Hoon Phi
    Journal of Korean Neurosurgical Society.2019; 62(3): 344.     CrossRef
  • Costs of informal nursing care for patients with neurologic disorders
    Freya Diederich, Hans-Helmut König, Claudia Mietzner, Christian Brettschneider
    Neurology.2018; 90(1): 28.     CrossRef
  • The Economic Burden of Hepatitis A, B, and C in South Korea
    Changwoo Shon, Hyung-Yun Choi, Jae-Jun Shim, So-Youn Park, Kyung Suk Lee, Seok-Jun Yoon, In-Hwan Oh
    Japanese Journal of Infectious Diseases.2016; 69(1): 18.     CrossRef
  • A nationwide epidemiological study of newly diagnosed spine metastasis in the adult Korean population
    Seil Sohn, Jinhee Kim, Chun Kee Chung, Na Rae Lee, Eunjung Park, Ung-Kyu Chang, Moon Jun Sohn, Sung Hwan Kim
    The Spine Journal.2016; 16(8): 937.     CrossRef
  • The direct costs of epilepsy in Russia. A prospective cost-of-illness study from a single center in Moscow
    Alla Guekht, Maria Mizinova, Igor Kaimovsky, Oksana Danilenko, Elisa Bianchi, Ettore Beghi
    Epilepsy & Behavior.2016; 64: 122.     CrossRef
The Socioeconomic Burden of Coronary Heart Disease in Korea
Hoo-Sun Chang, Han-Joong Kim, Chung-Mo Nam, Seung-Ji Lim, Young-Hwa Jang, Sera Kim, Hye-Young Kang
J Prev Med Public Health. 2012;45(5):291-300.   Published online September 28, 2012
DOI: https://doi.org/10.3961/jpmph.2012.45.5.291
  • 12,993 View
  • 118 Download
  • 31 Crossref
AbstractAbstract PDF
Objectives

We aimed to estimate the annual socioeconomic burden of coronary heart disease (CHD) in Korea in 2005, using the National Health Insurance (NHI) claims data.

Methods

A prevalence-based, top-down, cost-of-treatment method was used to assess the direct and indirect costs of CHD (International Classification of Diseases, 10th revision codes of I20-I25), angina pectoris (I20), and myocardial infarction (MI, I21-I23) from a societal perspective.

Results

Estimated national spending on CHD in 2005 was $2.52 billion. The majority of the spending was attributable to medical costs (53.3%), followed by productivity loss due to morbidity and premature death (33.6%), transportation (8.1%), and informal caregiver costs (4.9%). While medical cost was the predominant cost attribute in treating angina (74.3% of the total cost), premature death was the largest cost attribute for patients with MI (66.9%). Annual per-capita cost of treating MI, excluding premature death cost, was $3183, which is about 2 times higher than the cost for angina ($1556).

Conclusions

The total insurance-covered medical cost ($1.13 billion) of CHD accounted for approximately 6.02% of the total annual NHI expenditure. These findings suggest that the current burden of CHD on society is tremendous and that more effective prevention strategies are required in Korea.

Summary

Citations

Citations to this article as recorded by  
  • Comparative Review of the Socioeconomic Burden of Lower Back Pain in the United States and Globally
    Diana Chang, Austin Lui, Alisa Matsoyan, Michael M. Safaee, Henry Aryan, Christopher Ames
    Neurospine.2024; 21(2): 487.     CrossRef
  • Change in coronary heart disease hospitalization after chronic disease management: a programme policy in China
    Jingmin Zhu, Wei Wang, Jun Wang, Liang Zhu
    Health Policy and Planning.2023; 38(2): 161.     CrossRef
  • Direct medical costs of ischemic heart disease in urban Southern China: a 5-year retrospective analysis of an all-payer health claims database in Guangzhou City
    Peixuan Xie, Xuezhu Li, Feifan Guo, Donglan Zhang, Hui Zhang
    Frontiers in Public Health.2023;[Epub]     CrossRef
  • Hospitalization Expenses and Influencing Factors for Inpatients with Ischemic Heart Disease in Iran: A Retrospective Study
    Maryam Shirvani Shiri, Sara Emamgholipour Sefiddashti, Rajabali Daroudi, Maryam Tatary, Zohreh Kazemi, Hassan Karami
    Health Scope.2022;[Epub]     CrossRef
  • Social and Economic Costs and Health-Related Quality of Life in Patients With Acute Coronary Syndrome
    Saeed Sheikhgholami, Farbod Ebadifardazar, Aziz Rezapoor, Masih Tajdini, Mojtaba Salarifar
    Value in Health Regional Issues.2021; 24: 123.     CrossRef
  • Epidemiology of cardiovascular disease and its risk factors in Korea
    Hyeon Chang Kim
    Global Health & Medicine.2021; 3(3): 134.     CrossRef
  • Prevalence and socioeconomic burden of diabetes mellitus in South Korean adults: a population-based study using administrative data
    Sung-Hee Oh, Hyemin Ku, Kang Seo Park
    BMC Public Health.2021;[Epub]     CrossRef
  • Cost-Effectiveness Analysis of Positive Airway Pressure in Patient with Obstructive Sleep Apnea
    Hansol Kim, Jin Kook Kim, Jae Hoon Cho
    Journal of Rhinology.2021; 28(2): 94.     CrossRef
  • Health-economic burden of dementia in South Korea
    Changwoo Shon, Hyejung Yoon
    BMC Geriatrics.2021;[Epub]     CrossRef
  • The economic burden of chronic diseases: Estimates and projections for China, Japan, and South Korea
    David E. Bloom, Simiao Chen, Michael Kuhn, Mark E. McGovern, Les Oxley, Klaus Prettner
    The Journal of the Economics of Ageing.2020; 17: 100163.     CrossRef
  • Achievement of the low-density lipoprotein cholesterol goal among patients with dyslipidemia in South Korea
    Siin Kim, Sola Han, Pratik P. Rane, Yi Qian, Zhongyun Zhao, Hae Sun Suh, Luigina Guasti
    PLOS ONE.2020; 15(1): e0228472.     CrossRef
  • Direct and Indirect Costs Associated with Coronary Artery (Heart) Disease in Tabriz, Iran


    Shahla Darba, Naser Safaei, Alireza Mahboub–Ahari, Shirin Nosratnejad, Gisoo Alizadeh, Hosein Ameri, Mahmood Yousefi
    Risk Management and Healthcare Policy.2020; Volume 13: 969.     CrossRef
  • Estimation of the Economic Burden of Cardiovascular Diseases in Selected Hospitals of Yazd in 2018
    Mohsen Pakdaman, Sara Gravandi, Roohollah Askari, Milad Shafii, Mahdieh Khaleghi Muri, Sajjad Bahariniya
    Qom Univ Med Sci J.2020; 14(7): 58.     CrossRef
  • Socioeconomic Costs of Age-related Macular Degeneration in Korea
    Yongsun Ahn, Donghyun Jee
    Journal of the Korean Ophthalmological Society.2019; 60(8): 765.     CrossRef
  • Association of Thyroid-Stimulating Hormone and Thyroid Hormones with Cardiometabolic Risk Factors in Euthyroid Children and Adolescents Aged 10–18 Years: A Population-Based Study
    Cheol Gyu Ma, Young Suk Shim
    Scientific Reports.2019;[Epub]     CrossRef
  • Utilization Patterns of Lipid-lowering Therapies in Patients With Atherosclerotic Cardiovascular Disease or Diabetes: A Population-based Study in South Korea
    Siin Kim, Hyungtae Kim, Eunju Kim, Sola Han, Pratik P. Rane, Kathleen M. Fox, Zhongyun Zhao, Yi Qian, Hae Sun Suh
    Clinical Therapeutics.2018; 40(6): 940.     CrossRef
  • Sex differences in discharge destination following acute myocardial infarction
    Leor Perl, Véronique Peiffer, Audelia E. Fuhrer, Fabrizio D’Ascenzo, Jan B. Pietzsch
    Coronary Artery Disease.2018; 29(6): 502.     CrossRef
  • Prevalence and severity of coronary artery calcification based on the epidemiologic pattern: A propensity matched comparison of asymptomatic Korean and Chinese adults
    Donghee Han, Yang Gao, Bríain ó Hartaigh, Heidi Gransar, Ji Hyun Lee, Asim Rizvi, Su-Yeon Choi, Eun Ju Chun, Jidong Sung, Hae-Won Han, Sung Hak Park, James K. Min, Bin Lu, Hyuk-Jae Chang
    International Journal of Cardiology.2017; 230: 353.     CrossRef
  • Economic burden of chronic kidney disease in Korea using national sample cohort
    Seon-Ha Kim, Min-Woo Jo, Dun-Sol Go, Dong-Ryeol Ryu, Jongha Park
    Journal of Nephrology.2017; 30(6): 787.     CrossRef
  • Cost effectiveness of influenza vaccination in patients with acute coronary syndrome in Korea
    Jinuk Suh, Boyeon Kim, Yunseok Yang, Dong-Churl Suh, Eunyoung Kim
    Vaccine.2017; 35(21): 2811.     CrossRef
  • A nationwide epidemiological study of newly diagnosed spine metastasis in the adult Korean population
    Seil Sohn, Jinhee Kim, Chun Kee Chung, Na Rae Lee, Eunjung Park, Ung-Kyu Chang, Moon Jun Sohn, Sung Hwan Kim
    The Spine Journal.2016; 16(8): 937.     CrossRef
  • Reference Values for The Triglyceride to High-Density Lipoprotein Cholesterol Ratio and Non-High-Density Lipoprotein Cholesterol in Korean Children and Adolescents: The Korean National Health and Nutrition Examination Surveys 2007-2013
    Young Suk Shim, Joon Woo Baek, Min Jae Kang, Yeon Jeong Oh, Seung Yang, II Tae Hwang
    Journal of Atherosclerosis and Thrombosis.2016; 23(12): 1334.     CrossRef
  • Prevalence and Distribution of Coronary Artery Calcification in Asymptomatic United States and Korean Adults – Cross-Sectional Propensity-Matched Analysis –
    Donghee Han, Bríain ó Hartaigh, Heidi Gransar, Ji Hyun Lee, Su-Yeon Choi, Eun Ju Chun, Jidong Sung, Hae-Won Han, Sung Hak Park, Tracy Callister, Fay Y. Lin, James K. Min, Hyuk-Jae Chang
    Circulation Journal.2016; 80(11): 2349.     CrossRef
  • Productivity losses associated with cardiovascular disease: a systematic review
    Adam L Gordois, Peter P Toth, Ruben GW Quek, Emma M Proudfoot, Carly J Paoli, Shravanthi R Gandra
    Expert Review of Pharmacoeconomics & Outcomes Research.2016; 16(6): 759.     CrossRef
  • Trends in lipid profiles among South Korean adults: 2005, 2008 and 2010 Korea National Health and Nutrition Examination Survey
    Ga Eun Nam, Kyungdo Han, Yong Gyu Park, Youn Seon Choi, Seon Mee Kim, Sang-Yhun Ju, Byung-Joon Ko, Yang Hyun Kim, Eun Hye Kim, Kyung Hwan Cho, Do Hoon Kim
    Journal of Public Health.2015; 37(2): 286.     CrossRef
  • Economic burden and cost determinants of coronary heart disease in rural southwest China: a multilevel analysis
    C. Le, Y. Fang, W. Linxiong, Z. Shulan, A.R. Golden
    Public Health.2015; 129(1): 68.     CrossRef
  • Factors Predicting Nutrition and Physical Activity Behaviors Due to Cardiovascular Disease in Tehran University Students: Application of Health Belief Model
    Fatemeh Rahmati Najarkolaei, Sedigheh Sadat Tavafian, Mohammad Gholami Fesharaki, Mohammad Reza Jafari
    Iranian Red Crescent Medical Journal.2015;[Epub]     CrossRef
  • Admission route and use of invasive procedures during hospitalization for acute myocardial infarction: analysis of 2007-2011 National Health Insurance database
    Hyungseon Yeom, Dae Ryong Kang, Seong Kyung Cho, Seung Won Lee, Dong-Ho Shin, Hyeon Chang Kim
    Epidemiology and Health.2015; 37: e2015022.     CrossRef
  • Recent Trends in Economic Burden of Acute Myocardial Infarction in South Korea
    Hyeyoung Seo, Seok-Jun Yoon, Jihyun Yoon, Dongwoo Kim, Younghoon Gong, A. Rim Kim, In-Hwan Oh, Eun-Jung Kim, Yo-Han Lee, Chiara Lazzeri
    PLOS ONE.2015; 10(2): e0117446.     CrossRef
  • The Economic Burden of Self-Reported and Undiagnosed Cardiovascular Diseases and Diabetes on Indonesian Households
    Eric A. Finkelstein, Junxing Chay, Shailendra Bajpai, Ajay Mahal
    PLoS ONE.2014; 9(6): e99572.     CrossRef
  • The Incidence and Prevalence of Diabetes Mellitus and Related Atherosclerotic Complications in Korea: A National Health Insurance Database Study
    Bo Kyung Koo, Chang-Hoon Lee, Bo Ram Yang, Seung-sik Hwang, Nam-Kyong Choi, Mohammad Ebrahim Khamseh
    PLoS ONE.2014; 9(10): e110650.     CrossRef
English Abstracts
Socioeconomic Costs of Food-Borne Disease Using the Cost-of-Illness Model: Applying the QALY Method.
Hosung Shin, Suehyung Lee, Jong Soo Kim, Jinsuk Kim, Kyu Hong Han
J Prev Med Public Health. 2010;43(4):352-361.
DOI: https://doi.org/10.3961/jpmph.2010.43.4.352
  • 5,752 View
  • 131 Download
  • 20 Crossref
AbstractAbstract PDF
OBJECTIVES
This study estimated the annual socioeconomic costs of food-borne disease in 2008 from a societal perspective and using a cost-of-illness method. METHODS: Our model employed a comprehensive set of diagnostic disease codes to define food-borne diseases with using the Korea National Health Insurance (KNHI) reimbursement data. This study classified the food borne illness as three types of symptoms according to the severity of the illness: mild, moderate, severe. In addition to the traditional method of assessing the cost-of-illness, the study included measures to account for the lost quality of life. We estimated the cost of the lost quality of life using quality-adjusted life years and a visual analog scale. The direct cost included medical and medication costs, and the non-medical costs included transportation costs, caregiver's cost and administration costs. The lost productivity costs included lost workdays due to illness and lost earnings due to premature death. RESULTS: The study found the estimated annual socioeconomic costs of food-borne disease in 2008 were 954.9 billion won (735.3 billion won-996.9 billion won). The medical cost was 73.4 - 76.8% of the cost, the lost productivity cost was 22.6% and the cost of the lost quality of life was 26.0%. CONCLUSIONS: Most of the cost-of-illness studies are known to have underestimated the actual socioeconomic costs of the subjects, and these studies excluded many important social costs, such as the value of pain, suffering and functional disability. The study addressed the uncertainty related to estimating the socioeconomic costs of food-borne disease as well as the updated cost estimates. Our estimates could contribute to develop and evaluate policies for food-borne disease.
Summary

Citations

Citations to this article as recorded by  
  • Evaluation of Health Economic Loss Due to Particulate Matter Pollution in the Seoul Subway, South Korea
    Prakash Thangavel, Kyoung Youb Kim, Duckshin Park, Young-Chul Lee
    Toxics.2023; 11(2): 113.     CrossRef
  • Risk and socio-economic impact for Staphylococcus aureus foodborne illness by ready-to-eat salad consumption
    Yewon Lee, Hyemin Oh, Yeongeun Seo, Joohyun Kang, Eunyoung Park, Yohan Yoon
    Microbial Risk Analysis.2022; 21: 100219.     CrossRef
  • Risk assessment for norovirus foodborne illness by raw oyster (Ostreidae) consumption and economic burden in Korea
    Yoonjeong Yoo, Hyemin Oh, Yewon Lee, Miseon Sung, Jeongeun Hwang, Ziwei Zhao, Sunho Park, Changsun Choi, Yohan Yoon
    Fisheries and Aquatic Sciences.2022; 25(5): 287.     CrossRef
  • Does information on food safety affect consumers' acceptance of new food technologies? The case of irradiated beef in South Korea under a new labelling system and across different information regimes
    Vincenzina Caputo
    Australian Journal of Agricultural and Resource Economics.2020; 64(4): 1003.     CrossRef
  • Campylobacter control measures in indoor broiler chicken: critical re-assessment of cost-utility and putative barriers to implementation
    J. G. Pitter, Z. Vokó, Á Józwiak, A. Berkics
    Epidemiology and Infection.2018; 146(11): 1433.     CrossRef
  • The monetary value of human lives lost due to neglected tropical diseases in Africa
    Joses Muthuri Kirigia, Gitonga N. Mburugu
    Infectious Diseases of Poverty.2017;[Epub]     CrossRef
  • Identification of environmental determinants for spatio-temporal patterns of norovirus outbreaks in Korea using a geographic information system and binary response models
    Jin Hwi Kim, Dong Hoon Lee, Yongsung Joo, Kyung Duk Zoh, Gwangpyo Ko, Joo-Hyon Kang
    Science of The Total Environment.2016; 569-570: 291.     CrossRef
  • Expert opinions on improvement of current food code related to hygiene management standards for cooked foods in restaurants
    Seyoung Ju, Hyoseon Kawk, Wansoo Hong, Tongkyung Kwak, Hyeja Chang
    Journal of Nutrition and Health.2016; 49(3): 201.     CrossRef
  • Importance and Performance Analysis of Sanitation Management in Workers at Small and Medium Foodservice Industries Using HACCP Prerequisites
    Hyun-Jun Lee, Wan-Soo Hong
    Journal of the Korean Society of Food Science and Nutrition.2016; 45(10): 1497.     CrossRef
  • Emulsion PCR Improves the Specificity and Sensitivity of PCR-based Pathogen Detection
    Changhoon Chai
    Journal of Milk Science and Biotechnology.2016; 34(1): 43.     CrossRef
  • Cost-of-illness and disease burden of food-related pathogens in the Netherlands, 2011
    Marie-Josée J. Mangen, Martijn Bouwknegt, Ingrid H.M. Friesema, Juanita A. Haagsma, Laetitia M. Kortbeek, Luqman Tariq, Margaret Wilson, Wilfrid van Pelt, Arie H. Havelaar
    International Journal of Food Microbiology.2015; 196: 84.     CrossRef
  • Analysis of Foodborne Pathogens in Food and Environmental Samples from Foodservice Establishments at Schools in Gyeonggi Province
    Tae Young Oh, Seung-Youb Baek, Minseon Koo, Jong-Kyung Lee, Seung Min Kim, Kyung-Min Park, Daekeun Hwang, Hyun Jung Kim
    Journal of the Korean Society of Food Science and Nutrition.2015; 44(12): 1895.     CrossRef
  • Isothermal Target and Probe Amplification Assay for the Real-Time Rapid Detection of Staphylococcus aureus
    Hyewon Shin, Minhwan Kim, Eunju Yoon, Gyoungwon Kang, Seungyu Kim, Aelee Song, Jeongsoon Kim
    Journal of Food Protection.2015; 78(4): 723.     CrossRef
  • Next steps to evidence-based food safety risk analysis: opportunities for health technology assessment methodology implementation
    János G. Pitter, Ákos Jóźwiak, Éva Martos, Zoltán Kaló, Zoltán Vokó
    Studies in Agricultural Economics.2015; 117(3): 155.     CrossRef
  • Disease-Outcome Trees, EQ-5D Scores, and Estimated Annual Losses of Quality-Adjusted Life Years (QALYs) for 14 Foodborne Pathogens in the United States
    Michael Batz, Sandra Hoffmann, J. Glenn Morris
    Foodborne Pathogens and Disease.2014; 11(5): 395.     CrossRef
  • The economic burden of the 2009 pandemic H1N1 influenza in Korea
    Yang-Woo Kim, Seok-Jun Yoon, In-Hwan Oh
    Scandinavian Journal of Infectious Diseases.2013; 45(5): 390.     CrossRef
  • Antimicrobial Effect of Various Chopping Boards against Food-borne Bacteria
    Ji-Young Kim, Hyoung-Jae Lee, Jeong-Yong Cho, Hyun-Cheol Lim, Gyeong-Cheol Choi, Du-Woon Kim, Keun-Hyung Park, Jae-Hak Moon
    Korean Journal of Food Science and Technology.2012; 44(1): 114.     CrossRef
  • Effects of Dietary Supplementation of a New Probiotic CS61 Culture on Performance in Broiler Chickens
    Sung-Hwan Kim, In-Chul Lee, Hyung-Seon Baek, Seong-Soo Kang, Hyoung-Chin Kim, Jin-Cheol Yoo, Jong-Choon Kim
    Journal of Life Science.2012; 22(3): 340.     CrossRef
  • Annual Cost of Illness and Quality-Adjusted Life Year Losses in the United States Due to 14 Foodborne Pathogens
    Sandra Hoffmann, Michael B. Batz, J. Glenn Morris
    Journal of Food Protection.2012; 75(7): 1292.     CrossRef
  • Epidemiological Investigation for Outbreak of Food Poisoning Caused byBacillus cereusAmong the Workers at a Local Company in 2010
    Kum-Bal Choi, Hyun-Sul Lim, Kwan Lee, Gyoung-Yim Ha, Kwang-Hyun Jung, Chang-Kyu Sohn
    Journal of Preventive Medicine and Public Health.2011; 44(2): 65.     CrossRef
Socioeconomic Costs of Stroke in Korea: Estimated from the Korea National Health Insurance Claims Database.
Seung ji Lim, Han joong Kim, Chung mo Nam, Hoo sun Chang, Young Hwa Jang, Sera Kim, Hye Young Kang
J Prev Med Public Health. 2009;42(4):251-260.
DOI: https://doi.org/10.3961/jpmph.2009.42.4.251
  • 7,325 View
  • 147 Download
  • 42 Crossref
AbstractAbstract PDF
OBJECTIVES
To estimate the annual socioeconomic costs of stroke in Korea in 2005 from a societal perspective. METHODS: We identified those 20 years or older who had at least one national health insurance (NHI) claims record with a primary or a secondary diagnosis of stroke (ICD-10 codes: I60-I69, G45) in 2005. Direct medical costs of the stroke were measured from the NHI claims records. Direct non-medical costs were estimated as transportation costs incurred when visiting the hospitals. Indirect costs were defined as patients' and caregivers' productivity loss associated with office visits or hospitalization. Also, the costs of productivity loss due to premature death from stroke were calculated. RESULTS: A total of 882,143 stroke patients were identified with prevalence for treatment of stroke at 2.44%. The total cost for the treatment of stroke in the nation was estimated to be 3,737 billion Korean won (KRW) which included direct costs at 1,130 billion KRW and indirect costs at 2,606 billion KRW. The per-capita cost of stroke was 3 million KRW for men and 2 million KRW for women. The total national spending for hemorrhagic and ischemic stroke was 1,323 billion KRW and 1,553 billion KRW, respectively, which together consisted of 77.0% of the total cost for stroke. Costs per patient for hemorrhagic and ischemic stroke were estimated at 6 million KRW and 2 million KRW, respectively. CONCLUSIONS: Stroke is a leading public health problem in Korea in terms of the economic burden. The indirect costs were identified as the largest component of the overall cost.
Summary

Citations

Citations to this article as recorded by  
  • Healthcare expenditure trends among adult stroke patients in the United States, 2011-2020
    Venkataraghavan Ramamoorthy, Kelvin Chan, Mukesh Roy, Anshul Saxena, Md Ashfaq Ahmed, Zhenwei Zhang, Sandeep Appunni, Ronnie Thomas, Peter McGranaghan, Michael McDermott, Felipe De Los Rios La Rosa, Muni Rubens
    Journal of Stroke and Cerebrovascular Diseases.2023; 32(10): 107333.     CrossRef
  • Meta-analysis of risk factors associated with suicidal ideation after stroke
    Shuangmei Zhang, Anrong Wang, Weifeng Zhu, Zhaoyang Qiu, Zhaoxu Zhang
    Annals of General Psychiatry.2022;[Epub]     CrossRef
  • Associations of stroke with all-cause and cause-specific mortality: A population-based matched cohort study
    Juyeong Kim, Eun-Cheol Park
    Journal of Public Health.2022;[Epub]     CrossRef
  • Association between Stroke and Abdominal Obesity in the Middle-Aged and Elderly Korean Population: KNHANES Data from 2011–2019
    Jong Yeon Kim, Sung Min Cho, Youngmin Yoo, Taesic Lee, Jong Koo Kim
    International Journal of Environmental Research and Public Health.2022; 19(10): 6140.     CrossRef
  • The risk for future cerebrovascular disease in pregnant women with Moyamoya disease: a nationwide population-based study in South Korea
    Yeonseong Jeong, Yun Ji Jung, Eunjin Noh, Sungyeon Ha, Jeongeun Hwang, Geum Joon Cho, Min-Jeong Oh, Young-Han Kim
    BMC Pregnancy and Childbirth.2022;[Epub]     CrossRef
  • National Trends in Medical Costs and Prognosis of Acute Ischemic Stroke Patients in Endovascular Thrombectomy Era: Analysis Using Medical Claim Data in Korea
    Woo Sang Jung, Kwon-Duk Seo, Sang Hyun Suh
    Neurointervention.2022; 17(3): 152.     CrossRef
  • Relationship between Obsessive-compulsive Disorder and Overactive Bladder Syndrome
    Farzad Allameh, Mahtab Motamed, Mohammad Poury, Ali Tayyebiazar, Saleh Ghiasy, Morteza Fallah-Karkan, Saba Faraji, Seyyed Ali Hojjati
    Iranian Journal of Psychiatry and Behavioral Sciences.2021;[Epub]     CrossRef
  • Prevalence and socioeconomic burden of diabetes mellitus in South Korean adults: a population-based study using administrative data
    Sung-Hee Oh, Hyemin Ku, Kang Seo Park
    BMC Public Health.2021;[Epub]     CrossRef
  • The economic burden of chronic diseases: Estimates and projections for China, Japan, and South Korea
    David E. Bloom, Simiao Chen, Michael Kuhn, Mark E. McGovern, Les Oxley, Klaus Prettner
    The Journal of the Economics of Ageing.2020; 17: 100163.     CrossRef
  • Predictive costs in medical care for Koreans with metabolic syndrome from 2009 to 2013 based on the National Health Insurance claims dataset
    Jeong Seon Yoo, Eun Yeong Choe, Yoo Mee Kim, Se Hwa Kim, Young Jun Won
    The Korean Journal of Internal Medicine.2020; 35(4): 936.     CrossRef
  • Lifetime risks and health impacts of hemorrhagic and ischemic stroke in South Korea
    Soyeon Cheon, Hyangsook Lee, Jiyoon Won, Bo-Hyoung Jang, Jung-Der Wang
    Scientific Reports.2020;[Epub]     CrossRef
  • Comparative Study on the Outcome of Stroke Patients Transferred by Doctor Helicopters and Ground Ambulances in South Korea: A Retrospective Controlled Study
    Jeong Il Lee, Kang Hyun Lee, Oh Hyun Kim, Roberto Cirocchi
    Emergency Medicine International.2020; 2020: 1.     CrossRef
  • Propensity score matching analysis on inpatient period differences of hemorrhagic stroke survivors depending on medical insurance coverage
    Sang-Mi Kim, Young Kim, Seong-A Lee
    Physical Therapy Rehabilitation Science.2019; 8(2): 67.     CrossRef
  • Socioeconomic Costs of Age-related Macular Degeneration in Korea
    Yongsun Ahn, Donghyun Jee
    Journal of the Korean Ophthalmological Society.2019; 60(8): 765.     CrossRef
  • Disability Measurement for Korean Community-Dwelling Adults With Stroke: Item-Level Psychometric Analysis of the Korean Longitudinal Study of Ageing
    Ickpyo Hong, Young Joo Kim, Mandi L. Sonnenfeld, Emily Grattan, Timothy A. Reistetter
    Annals of Rehabilitation Medicine.2018; 42(2): 336.     CrossRef
  • The Economic Burden of Stroke Based on South Korea’s National Health Insurance Claims Database
    Yu-Jin Cha
    International Journal of Health Policy and Management.2018; 7(10): 904.     CrossRef
  • Changing Disease Trends in the Northern Gyeonggi-do Province of South Korea from 2002 to 2013: A Big Data Study Using National Health Information Database Cohort
    Young Soo Kim, Dong-Hee Lee, Hiun Suk Chae, Kyungdo Han
    Osong Public Health and Research Perspectives.2018; 9(5): 248.     CrossRef
  • A Nation-Wide Epidemiological Study of Newly Diagnosed Primary Spine Tumor in the Adult Korean Population, 2009-2011
    Seil Sohn, Jinhee Kim, Chun Kee Chung, Na Rae Lee, Moon Jun Sohn, Sung Hwan Kim
    Journal of Korean Neurosurgical Society.2017; 60(2): 195.     CrossRef
  • Analysis of Total Hospital Charges, Length of Stay, and Cost of Rehabilitation by Hospital and Stroke Type
    Sun-Mi Kim, Da-Yang Kim, Kwang-Soo Lee
    The Korean Journal of Health Service Management.2017; 11(1): 91.     CrossRef
  • The Economic Burden of Hepatitis A, B, and C in South Korea
    Changwoo Shon, Hyung-Yun Choi, Jae-Jun Shim, So-Youn Park, Kyung Suk Lee, Seok-Jun Yoon, In-Hwan Oh
    Japanese Journal of Infectious Diseases.2016; 69(1): 18.     CrossRef
  • Validation of Stroke and Thrombolytic Therapy in Korean National Health Insurance Claim Data
    Tai Hwan Park, Jay Chol Choi
    Journal of Clinical Neurology.2016; 12(1): 42.     CrossRef
  • Suicidal ideation and attempts in patients with stroke: a population-based study
    Jae Ho Chung, Jung Bin Kim, Ji Hyun Kim
    Journal of Neurology.2016; 263(10): 2032.     CrossRef
  • The Epidemiology and Economic Burden ofClostridium difficileInfection in Korea
    Hyung-Yun Choi, So-Youn Park, Young-Ae Kim, Tai-Young Yoon, Joong-Myung Choi, Bong-Keun Choe, So-Hee Ahn, Seok-Jun Yoon, Ye-Rin Lee, In-Hwan Oh
    BioMed Research International.2015; 2015: 1.     CrossRef
  • Antithrombotic treatment for stroke prevention in atrial fibrillation: The Asian agenda
    Chen-Huan Chen, Mien-Cheng Chen, Harry Gibbs, Sun U. Kwon, Sidney Lo, Young Keun On, Azhari Rosman, Nijasri C. Suwanwela, Ru San Tan, Louie S. Tirador, Andreas Zirlik
    International Journal of Cardiology.2015; 191: 244.     CrossRef
  • Nationwide epidemiology and healthcare utilization of spine tumor patients in the adult Korean population, 2009–2012
    Seil Sohn, Jinhee Kim, Chun Kee Chung, Na-Rye Lee, Eunjung Park, Ung-Kyu Chang, Moon Jun Sohn, Sung Hwan Kim
    Neuro-Oncology Practice.2015; 2(2): 93.     CrossRef
  • Direct medical cost of stroke in Singapore
    Charmaine Shuyu Ng, Matthias Paul Han Sim Toh, Jiaying Ng, Yu Ko
    International Journal of Stroke.2015; 10(SA100): 75.     CrossRef
  • Clinical characteristics of patients with treated epilepsy in Korea: A nationwide epidemiologic study
    Dong Wook Kim, Seo‐Young Lee, Soo‐Eun Chung, Hae‐Kwan Cheong, Ki‐Young Jung
    Epilepsia.2014; 55(1): 67.     CrossRef
  • The association between inhaled long-acting bronchodilators and less in-hospital care in newly-diagnosed COPD patients
    Jinhee Kim, Kyungjoo Kim, Yuri Kim, Kwang-Ha Yoo, Chin Kook Lee, Hyoung Kyu Yoon, Young Sam Kim, Young Bum Park, Jin Hwa Lee, Yeon-Mok Oh, Sang-Do Lee, Sei Won Lee
    Respiratory Medicine.2014; 108(1): 153.     CrossRef
  • Medical Utilization and Cost in Patients with Overlap Syndrome of Chronic Obstructive Pulmonary Disease and Asthma
    Chin Kook Rhee, Hyoung Kyu Yoon, Kwang Ha Yoo, Young Sam Kim, Sei Won Lee, Yong Bum Park, Jin Hwa Lee, Yuri Kim, Kyungjoo Kim, Jinhee Kim, Yeon Mok Oh, Sang Do Lee
    COPD: Journal of Chronic Obstructive Pulmonary Disease.2014; 11(2): 163.     CrossRef
  • The costs of hepatitis A infections in South Korea
    Kyohyun Kim, Baek-Geun Jeong, Moran Ki, Mira Park, Jin Kyung Park, Bo Youl Choi, Weon-Seob Yoo
    Epidemiology and Health.2014; 36: e2014011.     CrossRef
  • The Incidence and Prevalence of Diabetes Mellitus and Related Atherosclerotic Complications in Korea: A National Health Insurance Database Study
    Bo Kyung Koo, Chang-Hoon Lee, Bo Ram Yang, Seung-sik Hwang, Nam-Kyong Choi, Mohammad Ebrahim Khamseh
    PLoS ONE.2014; 9(10): e110650.     CrossRef
  • Two-Year Direct Medical Costs of Stroke in Korea: A Multi-Centre Incidence-Based Study from Hospital Perspectives
    Joung-Ho Rha, Jaseong Koo, Ki Hyun Cho, Eung-Gyu Kim, Gun Sei Oh, Se Jin Lee, Jae Kwan Cha, Jin-Jeong Oh, Gyoung-Rye Ham, Hyun-Soo Seo, Jong S. Kim
    International Journal of Stroke.2013; 8(3): 186.     CrossRef
  • Stroke Statistics in Korea: Part I. Epidemiology and Risk Factors: A Report from the Korean Stroke Society and Clinical Research Center for Stroke
    Keun-Sik Hong, Oh Young Bang, Dong-Wha Kang, Kyung-Ho Yu, Hee-Joon Bae, Jin Soo Lee, Ji Hoe Heo, Sun U. Kwon, Chang Wan Oh, Byung-Chul Lee, Jong S. Kim, Byung-Woo Yoon
    Journal of Stroke.2013; 15(1): 2.     CrossRef
  • The effect of severity of depressive disorder on economic burden in a university hospital in Singapore
    Roger CM Ho, Kwok-Kei Mak, Anna NC Chua, Cyrus SH Ho, Anselm Mak
    Expert Review of Pharmacoeconomics & Outcomes Research.2013; 13(4): 549.     CrossRef
  • The Socioeconomic Burden of Coronary Heart Disease in Korea
    Hoo-Sun Chang, Han-Joong Kim, Chung-Mo Nam, Seung-Ji Lim, Young-Hwa Jang, Sera Kim, Hye-Young Kang
    Journal of Preventive Medicine and Public Health.2012; 45(5): 291.     CrossRef
  • Prevalence of Dyslipidemia among Korean Adults: Korea National Health and Nutrition Survey 1998-2005
    Myung Ha Lee, Hyeon Chang Kim, Song Vogue Ahn, Nam Wook Hur, Dong Phil Choi, Chang Gyu Park, Il Suh
    Diabetes & Metabolism Journal.2012; 36(1): 43.     CrossRef
  • Itemized Hospital Charges for Acute Cerebral Infarction Patients Influenced by Severity in an Academic Medical Center in Korea
    Sung Sang Yoon, Hyejung Chang, Young Dae Kwon
    Journal of Clinical Neurology.2012; 8(1): 58.     CrossRef
  • The economic burden of stroke in 2010 in Korea
    Hyun-Jin Kim, Young-Ae Kim, Hye-Young Seo, Eun-Jung Kim, Seok-Jun Yoon, In-Hwan Oh
    Journal of the Korean Medical Association.2012; 55(12): 1226.     CrossRef
  • Prevalence of Treated Epilepsy in Korea Based on National Health Insurance Data
    Seo-Young Lee, Ki-Young Jung, Il Keun Lee, Sang Do Yi, Yong Won Cho, Dong Wook Kim, Seung-Sik Hwang, Sejin Kim
    Journal of Korean Medical Science.2012; 27(3): 285.     CrossRef
  • The Factors Associated with Good Responses to Speech Therapy Combined with Transcranial Direct Current Stimulation in Post-stroke Aphasic Patients
    Il-Young Jung, Jong Youb Lim, Eun Kyoung Kang, Hae Min Sohn, Nam-Jong Paik
    Annals of Rehabilitation Medicine.2011; 35(4): 460.     CrossRef
  • How Much Amount of Socioeconomic Loss Is Caused by Digestive Diseases?
    Kyung Sik Park
    The Korean Journal of Gastroenterology.2011; 58(6): 297.     CrossRef
  • Health Care Costs of Digestive Diseases in Korea
    Hye-kyung Jung, BoHyoung Jang, Youn Hee Kim, JooYeon Park, Sun Young Park, Mi-Hee Nam, Myung-Gyu Choi
    The Korean Journal of Gastroenterology.2011; 58(6): 323.     CrossRef
Economic Burden of Cancer in South Korea for the Year 2005.
Jinhee Kim, Myung Il Hahm, Eun Cheol Park, Jae Hyun Park, Jong Hyock Park, Sung Eun Kim, Sung Gyeong Kim
J Prev Med Public Health. 2009;42(3):190-198.
DOI: https://doi.org/10.3961/jpmph.2009.42.3.190
  • 6,813 View
  • 144 Download
  • 44 Crossref
AbstractAbstract PDF
OBJECTIVES
The objective of this study is to estimate the economic costs of cancer on society. METHODS: We estimated the economic burden of people with cancer in South Korea. To perform the analysis, we reviewed the records of people who were cancer patients and those who were newly diagnosed with cancer. The data was compiled from the National Health Insurance Corporation, which included the insurance claims database, a list of cancer patients, a database that records the cancer rates, the Korea Central Cancer Registry Center's cancer patient registry database and the Korea National Statistical Office's causes of death database. We classified the costs as related to cancer into direct costs and indirect costs, and we estimated each cost. Direct costs included both medical and non-medical care expenses and the indirect costs consisted of morbidity, mortality and the caregiver's time costs. RESULTS: The total economic costs of cancer in South Korea stood at 14.1 trillion won in 2005. The largest amount of the cost 7.4 trillion won, was the mortality costs. Following this were the morbidity costs (3.2 trillion won), the medical care costs (2.2 trillion won), the non-medical care costs (1.1 trillion won) and the costs related to the caregiver's time (100 billion won). As a result, the economic cost of cancer to South Korea is estimated to be between 11.6 trillion won to 14.1 trillion won for the year 2005. CONCLUSIONS: We need to reduce the cancer burden through encouraging people to undergo early screening for cancer and curing it in the early stage of cancer, as well as implementing policies to actively prevent cancer.
Summary

Citations

Citations to this article as recorded by  
  • Regional Health Disparities between Mortality Rates in Three Leading Causes of Death : A Comparative Study of Spatial Dependence in Local Death Rate between Cancer, Heart Disease, and Pneumonia
    Hee-Jung Jun, SeungYeoup Kang
    Journal of Korea Planning Association.2023; 58(2): 38.     CrossRef
  • Prevalence and socioeconomic burden of diabetes mellitus in South Korean adults: a population-based study using administrative data
    Sung-Hee Oh, Hyemin Ku, Kang Seo Park
    BMC Public Health.2021;[Epub]     CrossRef
  • Analysis of Medical Use and Treatment Costs of Hepatocellular Carcinoma Patients Using National Patient Sample Data
    Byeong-Chan Oh, Jeong-Yeon Cho, Sun-Hong Kwon, Eui-Kyung Lee, Hye-Lin Kim
    Korean Journal of Clinical Pharmacy.2021; 31(2): 153.     CrossRef
  • Sex Difference in the Socioeconomic Burden of Osteoporosis among South Koreans
    Eun-Whan Lee, Jin Young Nam
    Healthcare.2021; 9(10): 1304.     CrossRef
  • Socioeconomic Burden of Disease Due to Asthma in South Korea
    Eun-Whan Lee, Hee-Sun Kim, Wook Kim, Jin-Young Nam, Jae-Hyun Park
    Asia Pacific Journal of Public Health.2020; 32(4): 188.     CrossRef
  • The Economic Burden of Brain Disability in Korea, 2008-2011
    Hyun-Jin Kim, Seung Hee Ho, Sol Lee, In-Hwan Oh, Ju Hee Kim, Eun Joo Kim, Seong Jae Lee
    INQUIRY: The Journal of Health Care Organization, Provision, and Financing.2020; 57: 004695802093639.     CrossRef
  • Socioeconomic Burden of Cancer in Korea from 2011 to 2015
    Young Ae Kim, Ye-Rin Lee, Jeongjoo Park, In-Hwan Oh, Hoseob Kim, Seok-Jun Yoon, Keeho Park
    Cancer Research and Treatment.2020; 52(3): 896.     CrossRef
  • Measuring the Economic Burden of Disease and Injury in Korea, 2015
    Ye-Rin Lee, Bogeum Cho, Min-Woo Jo, Minsu Ock, Donghoon Lee, Doungkyu Lee, Moon Jung Kim, In-Hwan Oh
    Journal of Korean Medical Science.2019;[Epub]     CrossRef
  • The economic burden of cancer attributable to obesity in Korea: A population‐based cohort study
    Joo Eun Lee, Chung Mo Nam, Sang Gyu Lee, Sohee Park, Tae Hyun Kim, Eun‐Cheol Park
    European Journal of Cancer Care.2019;[Epub]     CrossRef
  • Association of Bedtime with both Suicidal Ideation and Suicide Planning among Korean Adolescents
    Wonjeong Jeong, Yun Kyung Kim, Hyeon Ji Lee, Jieun Jang, Selin Kim, Eun-Cheol Park, Sung-In Jang
    International Journal of Environmental Research and Public Health.2019; 16(20): 3817.     CrossRef
  • Cancer Survivorship in Primary Care
    Jihun Kang, Eun Ju Park, Jungkwon Lee
    Korean Journal of Family Medicine.2019; 40(6): 353.     CrossRef
  • The economic burden of kidney disorders in Korea
    Ju Hee Kim, Seung Hee Ho, Hyun-Jin Kim, Sol Lee
    Journal of Medical Economics.2018; 21(3): 262.     CrossRef
  • How great is current curative expenditure and catastrophic health expenditure among patients with cancer in China? A research based on “System of Health Account 2011”
    Ang Zheng, Wenjuan Duan, Lin Zhang, Xintong Bao, Xiaoyun Mao, Zhuojun Luo, Feng Jin
    Cancer Medicine.2018; 7(8): 4036.     CrossRef
  • The Burden of Cancer in Korea during 2012: Findings from a Prevalence-Based Approach
    Young-hoon Gong, Seok-Jun Yoon, Min-Woo Jo, Arim Kim, Young Ae Kim, Jihyun Yoon, Hyeyoung Seo, Dongwoo Kim
    Journal of Korean Medical Science.2016; 31(Suppl 2): S168.     CrossRef
  • Factors Influencing the of Middle-Aged Men the NCSP(National Cancer Screening Program)
    Geum-Ja Park, Kyoung-Min Lim, Sook-Nam Kim
    The Korean Journal of Health Service Management.2016; 10(3): 51.     CrossRef
  • Total costs and clinical outcome of hematopoietic stem cell transplantation in adults with leukemia: comparison between reduced‐intensity and myeloablative conditioning
    Koung Jin Suh, Inho Kim, Jin Lim, Hyerim Ha, Seongyeol Park, Youngil Koh, Sung‐Soo Yoon, Seonyang Park
    Clinical Transplantation.2015; 29(2): 124.     CrossRef
  • The Epidemiology and Economic Burden ofClostridium difficileInfection in Korea
    Hyung-Yun Choi, So-Youn Park, Young-Ae Kim, Tai-Young Yoon, Joong-Myung Choi, Bong-Keun Choe, So-Hee Ahn, Seok-Jun Yoon, Ye-Rin Lee, In-Hwan Oh
    BioMed Research International.2015; 2015: 1.     CrossRef
  • The Economic Burden of Cancer in Korea in 2009
    So Young Kim, Jong-Hyock Park, Kyoung Hee Kang, Inuk Hwang, Hyung Kook Yang, Young-Joo Won, Hong-Gwan Seo, Dukhyoung Lee, Seok-Jun Yoon
    Asian Pacific Journal of Cancer Prevention.2015; 16(3): 1295.     CrossRef
  • The Economic Burden of Cancers Attributable to Metabolic Syndrome in Korea
    Dongwoo Kim, Seok-Jun Yoon, Young-Hoon Gong, Young Ae Kim, Hye-Young Seo, Jihyun Yoon, A-Rim Kim
    Journal of Preventive Medicine and Public Health.2015; 48(4): 180.     CrossRef
  • The Economic Burden of Breast Cancer in Korea from 2007-2010
    Young Ae Kim, In-Hwan Oh, Seok-Jun Yoon, Hyun-Jin Kim, Hye-Young Seo, Eun-Jung Kim, Yo Han Lee, Jae Hun Jung
    Cancer Research and Treatment.2015; 47(4): 583.     CrossRef
  • Quality of Life among End-stage Renal Disease Treatments and Economic Evaluation of Renal Transplantation and Hemodialysis Treatments
    Kyung-Ock Jeon, Sun-Young Son, Myung-Il Hahm, Soon-Il Kim
    Korean Journal of Transplantation.2015; 29(4): 200.     CrossRef
  • Economic Burden of Colorectal Cancer in Korea
    Ju-Young Byun, Seok-Jun Yoon, In-Hwan Oh, Young Ae Kim, Hye-Young Seo, Yo-Han Lee
    Journal of Preventive Medicine and Public Health.2014; 47(2): 84.     CrossRef
  • Attributable fraction of alcohol consumption on cancer using population-based nationwide cancer incidence and mortality data in the Republic of Korea
    Sohee Park, Hai-Rim Shin, Boram Lee, Aesun Shin, Kyu-Won Jung, Duk-Hee Lee, Sun Ha Jee, Sung-Il Cho, Sue Kyung Park, Mathieu Boniol, Paolo Boffetta, Elisabete Weiderpass
    BMC Cancer.2014;[Epub]     CrossRef
  • Setting a Health Policy Research Agenda for Controlling Cancer Burden in Korea
    Sung-In Jang, Kyoung-Hee Cho, Sun Jung Kim, Kwang-Sig Lee, Eun-Cheol Park
    Cancer Research and Treatment.2014; 47(2): 149.     CrossRef
  • The costs of hepatitis A infections in South Korea
    Kyohyun Kim, Baek-Geun Jeong, Moran Ki, Mira Park, Jin Kyung Park, Bo Youl Choi, Weon-Seob Yoo
    Epidemiology and Health.2014; 36: e2014011.     CrossRef
  • Economic Burden of Cancer in Korea during 2000-2010
    Kwang-Sig Lee, Hoo-Sun Chang, Sun-Mi Lee, Eun-Cheol Park
    Cancer Research and Treatment.2014; 47(3): 387.     CrossRef
  • Review of Tumor Dormancy Therapy Using Traditional Oriental Herbal Medicine
    Jong-Ho Lee, Fan-Pei Koung, Chong-Kwan Cho, Yeon-Weol Lee, Hwa-Seung Yoo
    Journal of Pharmacopuncture.2013; 16(1): 12.     CrossRef
  • Management of Cancer Survivors in Clinical and Public Health Perspectives: Current Status and Future Challenges in Korea
    Dong Wook Shin, BeLong Cho, So Young Kim, Je Hyuck Jung, Jong Hyock Park
    Journal of Korean Medical Science.2013; 28(5): 651.     CrossRef
  • Disability Weights for Cancers in Korea
    Kyu Sik Choi, Jae Hyun Park, Kwang Sig Lee
    Journal of Korean Medical Science.2013; 28(6): 808.     CrossRef
  • Relationship Between Current Sleep Duration and Past Suicidal Ideation or Attempt Among Korean Adolescents
    Sung-In Jang, Kwang-Sig Lee, Eun-Cheol Park
    Journal of Preventive Medicine and Public Health.2013; 46(6): 329.     CrossRef
  • Union for International Cancer Control International Session: Healthcare Economics: The significance of the UN summit non‐communicable diseases political declaration in Asia
    Hideyuki Akaza, Norie Kawahara, Tohru Masui, Kunihiko Takeyama, Masafumi Nogimori, Jae Kyung Roh
    Cancer Science.2013; 104(6): 773.     CrossRef
  • A Single Measure of Cancer Burden in Korea from 1999 to 2010
    Kyoung-Hee Cho, Sohee Park, Kwang-Sig Lee, Sung-In Jang, Ki-Bong Yoo, Jae-Hyun Kim, Eun-Cheol Park
    Asian Pacific Journal of Cancer Prevention.2013; 14(9): 5249.     CrossRef
  • The Socioeconomic Burden of Coronary Heart Disease in Korea
    Hoo-Sun Chang, Han-Joong Kim, Chung-Mo Nam, Seung-Ji Lim, Young-Hwa Jang, Sera Kim, Hye-Young Kang
    Journal of Preventive Medicine and Public Health.2012; 45(5): 291.     CrossRef
  • Evaluation of the willingness‐to‐pay for cancer treatment in Korean metastatic breast cancer patients: A multicenter, cross‐sectional study
    Do‐Youn OH, Bruce CRAWFORD, Sung‐Bae KIM, Hyun‐Cheol CHUNG, Jeffrey MCDONALD, Sang Yoon LEE, Su‐Kyoung KO, Jungsil RO
    Asia-Pacific Journal of Clinical Oncology.2012; 8(3): 282.     CrossRef
  • The economic burden of stroke in 2010 in Korea
    Hyun-Jin Kim, Young-Ae Kim, Hye-Young Seo, Eun-Jung Kim, Seok-Jun Yoon, In-Hwan Oh
    Journal of the Korean Medical Association.2012; 55(12): 1226.     CrossRef
  • The Economic Burden of Inflammatory Heart Disease in Korea
    Seul-Ki Ko, Seok-Jun Yoon, In-Hwan Oh, Hye-Young Seo, Eun-Jung Kim
    Korean Circulation Journal.2011; 41(12): 712.     CrossRef
  • Needs Assessment for the Beneficiaries of Home-Based Cancer Patients Management Project
    Ju-Hyung Lee, Jung-Im Park, Ji-Hoon Kang, Jung-Ho Youm, Dai-Ha Koh, Keun-Sang Kwon
    Journal of agricultural medicine and community health.2011; 36(4): 238.     CrossRef
  • Socioeconomic costs of liver disease in Korea
    Sunmi Lee, Woojin Chung, Kyung-Rae Hyun
    The Korean Journal of Hepatology.2011; 17(4): 274.     CrossRef
  • How Much Amount of Socioeconomic Loss Is Caused by Digestive Diseases?
    Kyung Sik Park
    The Korean Journal of Gastroenterology.2011; 58(6): 297.     CrossRef
  • Comprehensive needs assessment tool in cancer (CNAT): the development and validation
    Eun-Jung Shim, kyung-Sook Lee, Jong-Hyock Park, Jae-Hyun Park
    Supportive Care in Cancer.2011; 19(12): 1957.     CrossRef
  • Factors Affecting Beneficiary Satisfaction on Financial Aid Program for Cancer Patients in Korea
    Ju-Ho Sim, Jong-Hyock Park, Jung-A Lee, So-Young Kim, Bo-Ram Park, Eun-Cheol Park
    Korean Journal of Health Policy and Administration.2011; 21(1): 61.     CrossRef
  • A Renal Transplantation and Hemodialysis Cost-Utility Analysis in Patients with End-Stage Renal Disease
    Soon-Il Kim, Yu-Seun Kim, Myoung-Soo Kim, Eun-Cheol Park, Kyung-Ock Jeon, Sun-young Son, Myung-Il Hahm, Hoo-Yeon Lee
    Korean Journal of Transplantation.2010; 24(3): 173.     CrossRef
  • Cancer patients' need for financial assistance and its related factors
    Youn-Gu Kim, Jae-Hyun Park, Jong-Hyock Park
    Korean Journal of Health Policy and Administration.2010; 20(4): 58.     CrossRef
  • Estimating Medical Expenditure Associated with Osteoporotic Hip Fracture in Elderly Korean Women Based on the National Health Insurance Claims Database 2002–2004
    Hye-Young Kang, Sung-Eun Park, Dae Ryong Kang, Ji Yoon Kim, Young Hwa Jang, Won-Jung Choi, Seong-Hwan Moon, Kyu-Hyun Yang, Jin-Young Park, Soon-Yong Kwon
    Value in Health.2009; 12: S93.     CrossRef
Original Article
Disability Weights for the Korean Burden of Disease Study: Focused on Comparison with Disability Weights in the Australian Burden of Disease Study.
Young Kyung Do, Seok Jun Yoon, Jung Kyu Lee, Young Hoon Kwon, Sang Il Lee, Changyup Kim, Kidong Park, Yong Ik Kim, Youngsoo Shin
J Prev Med Public Health. 2004;37(1):59-71.
  • 2,515 View
  • 90 Download
AbstractAbstract PDF
OBJECTIVE
This study aimed to measure the disability weights for the Korean Burden of Disease study, and to compare them with those adopted in the Australian study to examine the validity and describe the distinctive features. METHODS: The standardized valuation protocol was developed from the Global Burden of Disease (GBD) study and the Dutch Disability Weights study. Disability weights were measured for 123 diseases of the Korean version of Disease Classification by three panels of 10 medical doctors each. Then, overall distribution, correlation coefficients, difference by each disease, and mean of differences by disease group were analyzed for comparison of disability weights between the Korean and Australian studies. RESULTS: Korean disability weights ranged from 0.037 to 0.927. While the rank correlation coefficient was moderate to high (rs=0.68), Korean disability weights were higher than the corresponding Australian ones in 79.7% of the 118 diseases. Of these, war, leprosy, and most injuries showed the biggest differences. On the contrary, many infectious and parasitic diseases comprised the greater part of diseases of which Korean disability weights were lower. The mean of the differences was the highest in injuries of GBD disease groups, and in cardiovascular disease, injuries, and malignant neoplasm of the Korean disease category. CONCLUSION: Korean disability weights were found to be valid on the basis of overall distribution pattern and correlation, and are expected to be used as basic data for broadening the scope of burden of disease study. However, some distinctive features still remain to be explored in following studies.
Summary
Comparative Study
Disability Weights for Diseases in Korea.
Jung Kyu Lee, Seok Jun Yoon, Young Kyung Do, Young Hoon Kwon, Chang Yup Kim, Kidong Park, Yong Ik Kim, Young Soo Shin
Korean J Prev Med. 2003;36(2):163-170.
  • 15,066 View
  • 48 Download
AbstractAbstract PDF
OBJECTIVES
This study aimed to develop an evaluation protocol of disability weights using person trade-off, and to test the reliability of the developed protocol in a Korean context. METHODS: To develop the valuation protocol, the Global Burden of Disease (GBD) and the Dutch studies were replicated and modified. Sixteen indicator conditions were selected from the Korean version of disease classification, which was based on that of the GBD Study, and the person trade-off method referred to the Dutch method. RESULTS: The disability weights were valued in a two step panel study. The first step was a carefully designed group process by three panels, using person trade-off to establish the disability weights for sixteen selected indicator conditions. The second step consisted of interpolation of the remaining diseases, on a disability scale, by the individual members of three panels. The members of three panels were all medical doctors, with sufficient knowledge of the consequences of a broad variety of diseases. The internal consistency of the Korean disability weights was satisfactory. Considerable agreement existed within each panel and among the panels. CONCLUSIONS: It was feasible to use a modified evaluation protocol from those used in GBD and Dutch studies. This would provide a rational basis for an international comparative study of disability weights.
Summary
Original Article
Measuring the Burden of Major Cancers in Korea Using Healthy Life-Year (HeaLY).
Yong Jun Choi, Seok Jun Yoon, Chang Yup Kim, Youngsoo Shin
Korean J Prev Med. 2001;34(4):372-378.
  • 2,422 View
  • 38 Download
AbstractAbstract PDF
OBJECTIVES
This study introduced the healthy life-year(HeaLY), a composite indicator of disease burden, and used it to estimate the burden of major cancers in Korea. METHODS: We collected data from the national death certificate database, the national health insurance claims database and the abridged life table. This data was used to create a spreadsheet and estimate the burden of major cancers by sex in terms of HeaLYs. RESULTS: The burden of 10 major cancers for males was 2,248.97 person-year in terms of HeaLYs. Stomach cancer, liver cancer, and lung cancer were responsible for 75.2% of the burden of 10 major cancers The disease burden of 10 major cancers for females was estimated to be 1,567.58 person-years. About two thirds of HeaLYs lost were from stomach cancer, liver cancer, lung cancer, colorectal cancer, and breast cancer. The rankings among 10 major cancers were somewhat different in terms of both HeaLYs and deaths as the HeaLY method considers both mortality and morbidity. CONCLUSIONS: Despite the limitations of the data sources, we conclude that HeaLY can aid in setting policy priorities concerning major cancers by estimating the disease burden of these cancers. Time-series analysis of the disease burden using HeaLY and DALY will elucidate the strengths and weaknesses of both methods.
Summary
English Abstract
The Socioeconomic Cost of Diseases in Korea.
Young Ho Jung, Sukja Ko
J Prev Med Public Health. 2006;39(6):499-504.
  • 3,065 View
  • 44 Download
AbstractAbstract PDF
OBJECTIVES
The aim of the study was to estimate the annual socioeconomic cost of diseases in Korea. METHODS: We estimate both the direct and indirect costs of diseases in Korea during 2003 using a prevalence-based approach. The direct cost estimates included medical expenditures, traffic costs and caregiver's cost, and the indirect costs, representing the loss of production, included lost workdays due to illness and lost earnings due to premature death, which were estimated based on the human capital theory. The cost estimates were reported at three different discount rates (0, 3 and 5%). RESULTS: The cost of diseases in Korea during 2003 was 38.4 trillion won based on 0% discount rate. This estimate represents approximately 5.3% of GDP. The direct and indirect costs were estimated to be 22.5 trillion (58.5% of total cost) and 15.9 trillion won (41.5%), respectively. It was also found that the cost for those aged 40~49 accounted for the largest proportion (21.7%) in relation to age groups. The cost of diseases for males was 23.5% higher than that for females. For major diseases, the total socioeconomic costs were 16.0, 13.4, 11.3 and 11.19% for neoplasms, and diseases of the digestive, respiratory and circulatory systems, respectively. CONCLUSIONS: This study can be expected to provide valuable information for determining intervention and funding priorities, and for planning health policies.
Summary

JPMPH : Journal of Preventive Medicine and Public Health
TOP